Style | Citing Format |
---|---|
MLA | Abolghasemi S, et al.. "The Prevalence of Early Toxoplasmosis After Bone Marrow Transplantation Using Pcr: A Study in Iranian Patients." Infectious Disorders - Drug Targets, vol. 22, no. 7, 2022, pp. 62-66. |
APA | Abolghasemi S, Khederzadeh S, Salari S, Mardani M, Arabmazar Z, Ettefaghi M, Kamrani R, Ghorbi MD (2022). The Prevalence of Early Toxoplasmosis After Bone Marrow Transplantation Using Pcr: A Study in Iranian Patients. Infectious Disorders - Drug Targets, 22(7), 62-66. |
Chicago | Abolghasemi S, Khederzadeh S, Salari S, Mardani M, Arabmazar Z, Ettefaghi M, Kamrani R, Ghorbi MD. "The Prevalence of Early Toxoplasmosis After Bone Marrow Transplantation Using Pcr: A Study in Iranian Patients." Infectious Disorders - Drug Targets 22, no. 7 (2022): 62-66. |
Harvard | Abolghasemi S et al. (2022) 'The Prevalence of Early Toxoplasmosis After Bone Marrow Transplantation Using Pcr: A Study in Iranian Patients', Infectious Disorders - Drug Targets, 22(7), pp. 62-66. |
Vancouver | Abolghasemi S, Khederzadeh S, Salari S, Mardani M, Arabmazar Z, Ettefaghi M, et al.. The Prevalence of Early Toxoplasmosis After Bone Marrow Transplantation Using Pcr: A Study in Iranian Patients. Infectious Disorders - Drug Targets. 2022;22(7):62-66. |
BibTex | @article{ author = {Abolghasemi S and Khederzadeh S and Salari S and Mardani M and Arabmazar Z and Ettefaghi M and Kamrani R and Ghorbi MD}, title = {The Prevalence of Early Toxoplasmosis After Bone Marrow Transplantation Using Pcr: A Study in Iranian Patients}, journal = {Infectious Disorders - Drug Targets}, volume = {22}, number = {7}, pages = {62-66}, year = {2022} } |
RIS | TY - JOUR AU - Abolghasemi S AU - Khederzadeh S AU - Salari S AU - Mardani M AU - Arabmazar Z AU - Ettefaghi M AU - Kamrani R AU - Ghorbi MD TI - The Prevalence of Early Toxoplasmosis After Bone Marrow Transplantation Using Pcr: A Study in Iranian Patients JO - Infectious Disorders - Drug Targets VL - 22 IS - 7 SP - 62 EP - 66 PY - 2022 ER - |